VYNE Therapeutics Inc. (VYNE) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$570.0K

Net Income/Loss (FY2025)

-$26.5M

Total Assets (FY2025)

$30.2M

Total Equity (FY2025)

$27.8M

Cash Flows from Operating Activities (FY2025)

-$33.1M

Source: VYNE Therapeutics Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.